Delmar`s Dental Drug Reference
... The presentation of Dental Concerns and Client/Family Teaching are two of the most important features of the text. Such information provides the practitioner with a mechanism to assess the client before and after oral health care, prescribed drug therapy, to obtain and review specific items (assessm ...
... The presentation of Dental Concerns and Client/Family Teaching are two of the most important features of the text. Such information provides the practitioner with a mechanism to assess the client before and after oral health care, prescribed drug therapy, to obtain and review specific items (assessm ...
Diagnosis and Management of Rhinitis: Complete Guidelines of the
... the Joint Council on Allergy, Asthma and Immunology. The guidelines are comprehensive and begin with statements on clinical characteristics and diagnosis of different forms of rhinitis (allergic, non-allergic, occupational rhinitis, hormonal rhinitis [pregnancy and hypothyroidism], drug-induced rhin ...
... the Joint Council on Allergy, Asthma and Immunology. The guidelines are comprehensive and begin with statements on clinical characteristics and diagnosis of different forms of rhinitis (allergic, non-allergic, occupational rhinitis, hormonal rhinitis [pregnancy and hypothyroidism], drug-induced rhin ...
Rosacea in the Pediatric Population C M E
... Treatment is gradual and largely determined by the clinical type of rosacea. Children with early or intermediate stages of rosacea are encouraged to avoid their individual local triggers to prevent flares. Topical corticosteroids, especially fluorinated medications, should be discouraged, because ev ...
... Treatment is gradual and largely determined by the clinical type of rosacea. Children with early or intermediate stages of rosacea are encouraged to avoid their individual local triggers to prevent flares. Topical corticosteroids, especially fluorinated medications, should be discouraged, because ev ...
the europso psoriasis patient study
... respectively), although this tended to decline in respondents with moderate–severe psoriasis when compared with those with mild disease severity, as did satisfaction with a number of commonly used topical medications. In contrast, the high satisfaction reported with the use of systemic agents genera ...
... respectively), although this tended to decline in respondents with moderate–severe psoriasis when compared with those with mild disease severity, as did satisfaction with a number of commonly used topical medications. In contrast, the high satisfaction reported with the use of systemic agents genera ...
BOTOX FAQ: What is Botox? How do Botox injections work? What
... side effects such as pain, tenderness, swelling or bruising at the injection site are temporary and occur within a few days after treatment. Very rarely if the botox reaches the upper eyelid muscle there may be transient eyelid drooping also known as ptosis. This is the most significant risk and occ ...
... side effects such as pain, tenderness, swelling or bruising at the injection site are temporary and occur within a few days after treatment. Very rarely if the botox reaches the upper eyelid muscle there may be transient eyelid drooping also known as ptosis. This is the most significant risk and occ ...
The EAACI/GA2LEN/EDF/WAO Guideline for the definition
... This guideline is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the European Academy of Aller ...
... This guideline is the result of a systematic literature review using the ‘Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the European Academy of Aller ...
National drug formulay Ethiopia
... The selected strategy should be agreed with the patient; this agreement on outcome, and how it may be achieved, is termed concordance. The selected treatment can be non-pharmacological and/or pharmacological; it also needs to take into account the total cost of all therapeutic options. a. Non-pharma ...
... The selected strategy should be agreed with the patient; this agreement on outcome, and how it may be achieved, is termed concordance. The selected treatment can be non-pharmacological and/or pharmacological; it also needs to take into account the total cost of all therapeutic options. a. Non-pharma ...
... and no treatment. The treatment goal was to lower the IOP to < 24mmHg and at least 20% from baseline, unless it was already <19mmHg. The majority of the patients were white non-Hispanic (1132) followed by African Americans (389), and a minority of other racial groups (87). The study design, the pati ...
Full guideline
... means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to th ...
... means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to th ...
ETHIOPIAN NATIONAL DRUG FORMULARY First Edition
... The Formulary aims to provide standard information on drugs. And it targets all health professionals involved in patient care, training and research and others. Therefore the over all goal of the formularly is to help health professionals base their practice on solid information and knowledge to pro ...
... The Formulary aims to provide standard information on drugs. And it targets all health professionals involved in patient care, training and research and others. Therefore the over all goal of the formularly is to help health professionals base their practice on solid information and knowledge to pro ...
Leech Therapeutic Applications
... their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding ...
... their secretions, especially in their saliva. The blood-sucking annelids, leeches have been used for therapeutic purposes since the beginning of civilization. Ancient Egyptian, Indian, Greek and Arab physicians used leeches for a wide range of diseases starting from the conventional use for bleeding ...
Therapeutic Options for Uncontrolled Asthma
... equally applied in practice set-ups of developed and resource-poor (REP) countries, promoting one-size-fits-all approach etc.) are noted. This indicates that a collaborative composite approach is necessary involving all stakeholders for achieving optimal asthma control. Particularly practitioners ne ...
... equally applied in practice set-ups of developed and resource-poor (REP) countries, promoting one-size-fits-all approach etc.) are noted. This indicates that a collaborative composite approach is necessary involving all stakeholders for achieving optimal asthma control. Particularly practitioners ne ...
Endometritis in old mares - Pferdeheilkunde Equine Medicine
... resistance to conventional treatment does occur for various reasons. As a result of this, alternative or complementary treatment strategies have been developed. Some of these have been investigated with regards to mechanism of function and in controlled clinical studies, while the efficacy of other ...
... resistance to conventional treatment does occur for various reasons. As a result of this, alternative or complementary treatment strategies have been developed. Some of these have been investigated with regards to mechanism of function and in controlled clinical studies, while the efficacy of other ...
Vitiligo - Vitinomics.net
... A quality of life assessment should be made always during the first consultation, because there may be a difference between patient and physician assessment of severity, and it should be followed during treatment to assess patient satisfaction. Studies suggest that vitiligo imparts a mental and emot ...
... A quality of life assessment should be made always during the first consultation, because there may be a difference between patient and physician assessment of severity, and it should be followed during treatment to assess patient satisfaction. Studies suggest that vitiligo imparts a mental and emot ...
Endorphins, Exercise, and Addictions
... response of endorphin release to occur. Farrell (1985) assessed the threshold by looking at the effects of intensity and distance of running on endorphin-release in male subjects by compiling results from multiple studies with varied time and distances of running. Analyses of these data indicated a ...
... response of endorphin release to occur. Farrell (1985) assessed the threshold by looking at the effects of intensity and distance of running on endorphin-release in male subjects by compiling results from multiple studies with varied time and distances of running. Analyses of these data indicated a ...
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for
... Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘Health technologies’ are broadly defined as all interventions used to promote health, preve ...
... Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. ‘Health technologies’ are broadly defined as all interventions used to promote health, preve ...
voriconazole - Therapeutic Goods Administration
... In patients with moderate to severe renal dysfunction (creatinine clearance <50 mL/min), accumulation of the intravenous vehicle, SBECD, occurs. Oral voriconazole should be administered to patients with moderate to severe renal dysfunction including dialysis patients, unless an assessment of the ben ...
... In patients with moderate to severe renal dysfunction (creatinine clearance <50 mL/min), accumulation of the intravenous vehicle, SBECD, occurs. Oral voriconazole should be administered to patients with moderate to severe renal dysfunction including dialysis patients, unless an assessment of the ben ...
Treatment of Intracranial Dural Arteriovenous Fis
... Treatment options include conservative treatment, irradiation, TAE with particles or cyanoacrylate, and TVE. Recent studies of stereotactic radiation therapy for cavernous sinus dural AVFs showed a relatively high occlusion rate for the AVF (70%– 88%) several months after treatment without significa ...
... Treatment options include conservative treatment, irradiation, TAE with particles or cyanoacrylate, and TVE. Recent studies of stereotactic radiation therapy for cavernous sinus dural AVFs showed a relatively high occlusion rate for the AVF (70%– 88%) several months after treatment without significa ...
MS_Word ~ 296 KB
... extensive number of immune mediated medical conditions, in addition to B-cell malignancies, for which rituximab has been used. There are also many other variables that make systematic interpretation of the evidence difficult. These include: • Variations in the exact rituximab regimen used - even for ...
... extensive number of immune mediated medical conditions, in addition to B-cell malignancies, for which rituximab has been used. There are also many other variables that make systematic interpretation of the evidence difficult. These include: • Variations in the exact rituximab regimen used - even for ...
the EHC Israeli National Member Organisation
... concentrates. Sébastien notes great differences between his younger and older patients, with younger patients who have been on prophylaxis since birth having much better joint protection compared to older generations who had not received good treatment in their youth. Furthermore, when patients have ...
... concentrates. Sébastien notes great differences between his younger and older patients, with younger patients who have been on prophylaxis since birth having much better joint protection compared to older generations who had not received good treatment in their youth. Furthermore, when patients have ...
Ezetimibe / Rosuvastatin - Therapeutic Goods Administration
... faeces and urine, respectively, over a 10-day collection period. After 48 hours, there were no detectable levels of radioactivity in the plasma. Rosuvastatin In a bioequivalence study comparing 40 mg MSD ROSUVASTATIN tablets with the innovator’s tablets, following an oral administration of a single- ...
... faeces and urine, respectively, over a 10-day collection period. After 48 hours, there were no detectable levels of radioactivity in the plasma. Rosuvastatin In a bioequivalence study comparing 40 mg MSD ROSUVASTATIN tablets with the innovator’s tablets, following an oral administration of a single- ...
Systematic Review and Meta-Analysis on the Nonsurgical Treatment
... and erbium), systemic antimicrobials, and systemic sub-antimicrobial dose doxycycline. Systemic antimicrobials were categorized separately from systemic sub-antimicrobial dose doxycycline because the mechanisms of action are different. The mechanism of action for subantimicrobial dose doxycycline ha ...
... and erbium), systemic antimicrobials, and systemic sub-antimicrobial dose doxycycline. Systemic antimicrobials were categorized separately from systemic sub-antimicrobial dose doxycycline because the mechanisms of action are different. The mechanism of action for subantimicrobial dose doxycycline ha ...
... the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.